Pheast Therapeutics
Latest round
- Series A
Last raised
- Apr 2022
Total raised
- $76M
Investors
- 4
About Pheast Therapeutics
Based in California, US, and founded in 2020 by Amira Barkal, Pheast Therapeutics, Inc activates the immune system to pheast on cancer. In April 2022, Pheast Therapeutics, Inc. The company is focused on developing novel checkpoint therapies to harness the innate immune system in the fight against cancer. The firm has developed CD47 as a "don't eat me" signal and is critical to the advancement of CD47-targeting clinical programs to treat multiple hematologic malignancies. The company is targeting an entirely new signaling axis through their CD24 pipeline which has shown promise in animals for treating ovarian cancer, breast cancer, and other solid tumors. The company is also leveraging its proprietary discovery platform to enable the development of additional novel tumor-specific cancer immunotherapies.
Who invested in Pheast Therapeutics
4 investors across 1 round
See all investors in Pheast Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Apr 26, 2022
Amount
$76M
Investors
Questions about Pheast Therapeutics
Who invested in Pheast Therapeutics?
Pheast Therapeutics has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Pheast Therapeutics raised?
Pheast Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Pheast Therapeutics last raise money?
Pheast Therapeutics's most recent round on record is a Series A, in Apr 2022.
What does Pheast Therapeutics do?
Based in California, US, and founded in 2020 by Amira Barkal, Pheast Therapeutics, Inc activates the immune system to pheast on cancer.
Where is Pheast Therapeutics headquartered?
Pheast Therapeutics is headquartered in Palo Alto, US.
Which VCs invest in companies like Pheast Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Pheast Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Pheast Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.